Ke Xu

Tianjin Medical University General Hospital China

Professor Ke Xu earned his BSc in Microbiology from Nankai University (China) and his Ph.D. in Cell and Molecular Biology from the University of Essex (UK). He completed his postdoctoral training at the Institute of Cancer Research (UK), working on leukemia. Professor Ke Xu conducted his research fellowship at Imperial College London (UK), investigating gene targeting and lung cancer. He joined the Tianjin Lung Cancer Institute of Tianjin Medical University General Hospital (China) in 2007 as a principal investigator, studying tumor microenvironment and novel anti-cancer drugs. Professor Ke Xu is an active member of the American Association for Cancer Research, the European Association for Cancer Research, the American Society for Cell Biology, and the Chinese Anti-Cancer Association.

Ke Xu

5books edited

Latest work with IntechOpen by Ke Xu

Metastasis is the leading cause of cancer-related death, and metastasis is also the major obstacle to cancer treatment. Despite the advances in metastasis research, the mechanism underlying metastasis is not fully understood. Further study on metastasis will help expand our knowledge of cancer and develop novel therapeutic strategies for cancer management. This book presents the latest advances in mechanism, diagnosis, prognosis and targeted therapy of cancer metastasis.

Go to the book